SUMMARY. The complexity of the RHD and RHCE genes, which is the greatest of all blood group systems, confounds analysis at the molecular level. RH DNA typing was introduced in 1993 and has been applied to prenatal testing. PCR-SSP analysis covering multiple polymorphisms was recently introduced for the screening and initial characterization of partial D. Our objective is to summarize the accrued knowledge relevant to the approaches to Rh phenotype prediction by DNA typing, their possible applications beyond research laboratories and their limitations. The procedures, results and problems encountered are highly detailed. It is recommended that DNA typing comprises an analysis of more than one polymorphism. We discuss future directions and propose a piecemeal approach to improve reliability and costefficiency of blood group genotyping that may eventually replace the prevalent serology-based techniques even for many routine tasks. Transfusion medicine is in the unique position of being able to utilize the most extensive phenotype databases available to check and develop genotyping strategies.
The genes of almost all blood group systems have been cloned and the molecular bases of their major antigens elucidated. Hence, DNA typing has become possible for many blood group antigens that are mostly defined by single amino acid polymorphisms and expressed by proteins of the red blood cell surface (Anstee, 1995; Avent, 1997; Huang, 1997b) . Suitable PCR techniques for genotyping of ABO (Gassner et al., 1996) , Kell (Hessner et al., 1996) , Duffy (Mallinson et al., 1995) , Kidd (Olives et al., 1997) , MN and Ss (Eshleman et al., 1995) have been described. In a similar fashion, DNA typing for alleles of both RH genes can be performed.
The first application of Rh phenotype prediction by DNA typing was published in 1993 (Bennett et al., 1993; Lo et al., 1993) . A rather high rate of false positive results (Simsek et al., 1994) and false negative results (Bennett & Cartron, 1994; Simsek et al., 1994) was immediately recognized and the authors proposed that 'the use of two independent primer sets should reduce the risk of incorrect genotyping.' (Bennett & Cartron, 1994; Simsek et al., 1994) . Many polymorphisms have been utilized for RhD phenotype prediction since then (previously reviewed by Wolter et al., 1993; Hyland et al., 1995; van den Veyver & Moise, 1996; Aubin et al., 1997) . No consensus has yet been achieved as to which polymorphism may be most reliable for testing of any given population.
RH and particularly RHD DNA typing is much confounded by the presence of two highly homologous genes, RHCE and RHD, and the complex polymorphisms between both genes. In contrast to most other blood group antigens, the RhD antigen does not derive from amino acid polymorphisms, but from the presence of a separate protein absent in the RhD-negative phenotypes. Furthermore, there are proteins, such as R 0
Har and D VI , that express RhD-immunoreactivity but do not share any common RHD-specific nucleotide sequences. To establish reliable and workable solutions for RH DNA typing Transfusion Medicine, 1998, 8, 281-302 281 is probably the most challenging task among all blood group genotyping applications.
The discrimination of RHD homozygotes from RHD heterozygotes is hampered (Cossu et al., 1996) because the most prevalent RHD-negative allele cannot yet be detected specifically. For the time being, we prefer therefore the term DNA typing rather than genotyping, when an RhD phenotype prediction by molecular techniques is attempted.
We have summarized the molecular genetics of the RH genes according to the current understanding. A list of RHD alleles, catalogued by molecular rather than serological criteria, and of polymorphisms between RHD and RHCE, useful for DNA typing, is provided. The development of suitable DNA techniques is discussed. We present a survey of published RH DNA typing methods. The propagation of DNA typing methods for blood groups, like Rh, from the benches of some specialized laboratories to a widely established routine tool for transfusion medicine is under way. Efficient and affordable solutions should be widely adapted.
CLINICAL SIGNIFICANCE
The first application of RH DNA typing was prenatal testing for fetal RhD status to indicate the requirement for anti-D prophylaxis and clinical management of pregnant women with anti-D (Bennett et al., 1993; Lo et al., 1993) . DNA typing may require less fetal tissue and can be performed before the Rh proteins are expressed, rendering the fetal DNA typing less invasive than serological phenotyping. The DNA typing can be done with any fetal tissue, such as amniotic fluid ('amniocytes'), trophoblastic cells ('chorionic villi') or cord blood ('fetal blood cells'). Essentially noninvasive methods for fetal testing by retrieving fetal (trophoblastic) cells shed into the endocervical canal (Adinolfi et al., 1995) or fetal cells circulating in the mother's peripheral blood (Lo et al., 1994a,b) appear possible. For the latter application, selection of the appropriate fetal cell type is crucial, because fetal lymphocytes may persist for many years in the mother's circulation (Bianchi et al., 1996) preventing a meaningful test interpretation in multiparous women. Recent approaches stressed the importance of test sensitivity (Hengstschlager et al., 1997; Tonn et al., 1997) and focused on fetal nucleated red blood cells, which may be enriched (Gänshirt-Ahlert et al., 1993; Busch et al., 1994; Geifman-Holtzman et al., 1996b; Sekizawa et al., 1996) , tested as single cells (Ferguson-Smith et al., 1994; van den Veyver et al., 1995; Sekizawa et al., 1996; Reubinoff et al., 1996) or assayed for RHD mRNA (Hamlington et al., 1997) . Prenatal genotyping has already been applied to many other blood group proteins like RhCE Spence et al., 1995b; Dildy et al., 1996; Geifman-Holtzman et al., 1996a) , Kell (Lee et al., 1996; Spence et al., 1997) , MN and Ss (Eshleman et al., 1995) .
Other applications of RH DNA typing are in paternity testing and forensic medicine (Ikemoto et al., 1996) . Like all genetic testing, RH DNA typing would be feasible with any source of human tissue carrying nucleated cells or remnants thereof, including blood, serum, plasma, skin, hair, hair follicle, bone, semen or urine.
Emerging evidence is pointing to the possibility that DNA-based phenotype prediction is superior to serotyping, when serological typing cannot be accomplished with its usual ease. After massive transfusion of blood components, the serological typing is frequently hampered by the admixture of allogeneic red blood cells obscuring the recipient's antigens. Despite the transfer of donor leucocytes, DNA typing was feasible for HLA (Wenk & Chiafari, 1997) , MN and Ss (Eshleman et al., 1995) . It seems promising that suitable methods will be developed for other blood groups so that a reliable typing can be provided even after massive transfusions. In partial D with reduced antigen density, serological discrimination is often hampered by limiting antibody sensitivity. DNA-based phenotype prediction was shown to be superior to serological discrimination of such RhD phenotypes, as exemplified by the different D VI types (Wagner et al., 1998a) . The relevance of RH DNA typing for clinical management depends critically on the reliability of the Rh phenotype prediction. Allele variants, especially RHD/ CE hybrid alleles, and random nucleotide substitutions in the gene account for discrepancies between the results of DNA-based phenotype prediction and of serology-based phenotyping. RH genotyping may eventually replace current serological Rhesus testing, if two major obstacles can be overcome. A more comprehensive understanding of the RH locus and its variant organization in different populations needs to be achieved and, more importantly, the cost-efficiency needs to be vastly improved.
SCIENTIFIC SIGNIFICANCE
A unique combination of features applying to the RH genes and Rh proteins qualifies them as an attractive model system. They represent two highly homologous genes that are located closely adjacent on a chromosome. Their polymorphism is shaped by a recent duplication and later deletion events. A multitude of gene conversion and recombination events are evident from the limited characterization of the extant alleles, which has been conducted to date. With a prudent combination of serological and molecular screens the knowledge will soon increase considerably. Hence, the RH polymorphism presents itself as a model system for the group of homologous adjacent genes, which comprise a large number of members and are frequent throughout the genomes of all species. With the exception of the HLA genes' locus the RH genes already represent the best characterized members of that group. It is a potential advantage that in contrast to HLA the Rh proteins do not seem to be exposed to stringent selective pressure and may therefore represent more faithfully the processes involved in near-random molecular evolution.
RH allele polymorphism will also be of interest to population biology because it has become feasible to determine in a massive way the frequencies of molecularly defined rare alleles in natural populations. Poissonlike allele distributions were predicted by mathematical models (Joyce & Tavare, 1995) , which have so far not been checked in any real population.
The observation of alleles with multiple nucleotide substitutions in the RHD gene that were characteristic for the RHCE gene, but interspersed by RHD-specific DNA segments, cannot be explained by a single gene conversion event. This observation pointed to more complicated mechanisms shaping the polymorphism of proteins. The occurrence of various Rh proteins seems to represent a natural experiment for protein membrane integration. The mechanisms involved can be more completely explained once the function of the Rh protein has been discerned and the relationship of function and protein morphology has been checked.
RELEVANCE OF THE MOLECULAR GENETICS OF THE RH LOCUS
All antigens of the Rh blood group system are carried by two proteins encoded by two highly homologous genes, RHD and RHCE, with adjacent chromosomal positions. Recent reviews (Cartron, 1994; Rouger & Muller, 1996; Huang, 1997b; Scott et al., 1997; summarize the accrued knowledge. The genes were derived from an older duplication process that was followed far more recently by a deletion encompassing the whole RHD gene in the prevalent RhDnegative haplotype. The allelic variability known from serological studies was confirmed by the current molecular work-up, which revealed many more alleles than anticipated by serology. A multitude of genetic mechanisms seems to have contributed to this allelic variability including multiple exchanges of DNA stretches between or recombination events affecting both genes, and numerous nucleotide substitutions occurring in both genes (Carritt et al., 1997) .
The complex organization of the RH locus ( Fig. 1) Fig. 1 . Chromosomal organization of the RHCE and RHD genes according to the current understanding. The locus (top) spans less than 450 kb on the short arm of chromosome 1 between the positions 1p34·3 and 1p36·1 MacGeoch et al., 1992) . The physical distance between both genes is unknown. The RHD gene is located 3 0 to the RHCE gene. The orientation of the genes in regard to each other and to the centromere is still unresolved. The genomic structure was analysed for the RHCE gene (CherifZahar et al., 1994) . The RHD gene is believed to have a very similar structure (bottom). There are 37 amino acid positions varying between the ce allele of RHCE and the prevalent RHD allele (thin lines in the 10 exons). The 3 0 untranslated region (UTR) of RHD exon 10 (hatched) covers more than 1500 bp (Le Van Kim et al., 1992) ; a shorter stretch is known for RHCE (Cherif-Zahar et al., 1990) , which deviated considerably (asterisks above 3 0 UTR). Many of these exon polymorphisms have been utilized to detect the presence of the RHD allele (see Table 1 ). There is a 4247-bp stretch of near nucleotide identity between the C allele of RHCE and the RHD alleles spanning from intron 1 to intron 2 (asterisks around exon 2). The positions of nucleotide deletions occurring in introns of the RHCE gene are indicated by arrows: All three deletions (109 bp in intron 2, 288 bp in intron 3 and 651 bp in the very short intron 4) have been utilized for DNA typing to detect the presence of the RHD allele (see Table 4 ).
its exploitation for DNA typing. Whilst understanding of the arrangement of the RH genes is far from complete, many polymorphisms between both genes along with allele polymorphisms have been established. Apart from exon sequences, polymorphisms in intron 2 , 3 (Wagner et al., 1998a) , 4 (Arce et al., 1993) and 8 Carritt et al., 1997) were utilized to predict the phenotype for many Rh antigens. Examples for 'diagnostic sites' suitable for PCR using sequence-specific priming are given in Table 1 .
Partial D phenotypes
Anti-D immunization in RhD-positive individuals (Argall et al., 1953) was exploited to classify some RhD proteins into 'D categories' (Tippett & Sanger, 1962) . The term 'partial D' (Salmon et al., 1984) (Wagner et al., 1998b) .
Several of these RHD alleles with aberrant RHD coding sequences are clinically important. Their discrimination from the prevalent RHD allele in transfusion recipients would be advantageous to guide RhD-negative transfusion therapy. The best characterized partial D to be set apart from RhD-positive in routine serological testing are the different D VI types (Wagner et al., 1998a) . However, as more data for the partial D population frequencies Roubinet et al., 284 W. A. Flegel et al. ᭧ 1998 Blackwell Science Ltd, Transfusion Medicine, 8, 281-302 The specificity is indicated for the prevalent alleles at the RH locus in Caucasians. Rare alleles may limit the specificity as discussed in the text (see Tables 2 and 3 ). At least one nucleotide position in each exon and intron with known polymorphisms is tested. There are no polymorphisms in exon 8 or in the coding sequence of exon 10 (see Fig. 1 ) and no suitable polymorphism for SSP in intron 3. D VII represents RHD(L110P); C w -RHC(Q41R); c(cyt48) -the c(W16C) allele of RHCE which is frequent in the cDe haplotype and serologically indistinguishable from the prevalent c alleles of RHCE ; 3 0 UTR -3 0 untranslated region of exon 10; n.a. -not applicable because of intronic location of the polymorphism. Primer sequences may be found in Gassner et al. (1997b) and for intron 4 in Avent et al. (1997c) . For intron 2, C w and D VII the method is given in Gassner et al. (1997a) , although no PCR-SSP primer sequences have yet been published.
1996) and the propensity for immunization by RhDpositive transfusion and pregnancy are gathered, the specific detection of other partial D may become desirable.
Weak D antigen expression
In contrast to the previously accepted dogma (Issitt & Telen, 1996; Roubinet et al., 1996; Rouillac et al., 1996; Aubin et al., 1997; Beckers et al., 1997; Fukumori et al., 1997; Huang, 1997b) , the vast majority of RHD alleles found with weak D antigen expression encode aberrant RhD with amino acid substitutions .
We noted that in all weak D samples characterized at the molecular level the substituted residues were located in transmembranous and intracellular RhD protein segments (Wagner et al., 1998b) .
Towards a molecular-based Rh nomenclature
For the purpose of an RH-allele-based nomenclature, we would favour the term 'aberrant RHD' allele referring to all RHD alleles coding for one or more amino acid substitutions compared to the prevalent, standard RHD allele. This DNA-based definition would broaden the serology-based definition of partial D and encompass a wider range of RHD alleles and the proteins/antigens encoded by these alleles. The name reflects the sporadic occurrence of these alleles and, hence, of their 'aberrant RhD' phenotypes, including but not limited to partial D. The proposed nomenclature has the advantage of covering almost all known RHD alleles (Table 2 ) including all known clinically relevant partial D and molecular weak D types (Wagner et al., 1998b) . The nomenclature is unequivocally defined and does not depend on the availability of suitable anti-D. With regard to RHCE, for example, the Rh33 allele and its protein would likewise be called aberrant RHCE and aberrant RhCE. Null alleles of the RHD gene, which are associated with ineffective RhD protein expression, like RHD(Q41X) (Avent et al., 1997c) , may be referred to as nonfunctional RHD.
RhD-negative phenotype and nonfunctional alleles
The characterization of molecular structure(s) underlying the RHD-negative haplotype is incomplete. Lack of the whole RHD gene leads to the prevalence of the RhDnegative phenotype Arce et al., 1993) . Only the knowledge of the RHD-negative molecular structure(s) in various populations will permit 'RH genotyping' for RhD phenotype prediction in the future. It is noteworthy that nonfunctional alleles generally occur rather frequently in most genes, as originally shown by electrophoresis studies of enzymes in Drosophila melanogaster (Langley et al., 1981; Ohnishi et al., 1982) . Similar results were obtained for the population frequency of nonfunctional alleles in the human H transferase gene (FUT1) (Wagner & Flegel, 1997) . The majority of nonfunctional alleles are due to mis-sense, frame shift and non-sense mutations in the coding sequence (Cooper & Krawczak, 1993) ; promoter defects, loss of start codon and alterations of splice sites may also occur. Nonfunctional alleles are of principal practical importance for the specificity of any genotyping strategy aiming for a phenotype prediction (Flegel, 1997) .
Thus, it was not surprising frequently to encounter RhD-negative samples harbouring RHD-specific DNA stretches (Table 3 ). This list of nonfunctional RHD alleles is expected to grow considerably. Their more frequent occurrence among RhD-negative samples in non-Caucasian populations (Daniels et al., 1997; Fukumori et al., 1997; Okuda et al., 1997) is explained in part by the lower prevalence of RhD-negative phenotypes in these populations. These alleles confound DNA typing, because they are refractory to some, most or all current DNA typing approaches.
The Rh null phenotype of the regulator variant (CherifZahar et al., 1996; Hyland et al., 1998) may carry an intact and functional RHD allele and, hence, cannot be specifically detected by any molecular analysis of the RH gene locus. Fortunately, this phenotype is even less frequent than the very rare Bombay phenotype in Caucasians (Wagner et al., 1995) .
GENERAL TECHNICAL ASPECTS FOR DNA TYPING TECHNIQUES
DNA typing by PCR requires sample preparation and nucleic acid extraction; amplification of the desired 'diagnostic' DNA fragments; and the specific detection of the amplicons. Robust methods, starting from the sample preparation to the final interpretation of the results, are mandatory for any genotyping strategy. The development of convenient procedures and reliable instrumentation is anticipated to allow efficient and safe handling. The total number of pipetting and transfer steps should be minimized to avoid contamination and sample mix-ups. Automatic pipetting robots are available for contamination-free and reliable pipetting of small volumes of reagents.
DNA extraction and DNA amplification by PCR
Extraction of DNA from the biological sample deserves special attention to ensure adequate purity (including efficient removal of inhibitors such as haemoglobin) and adequate yield (even with relatively low numbers of amniotic cells) for the ensuing PCR. Adsorption-based extraction methods (e.g. spin-columns) have been weak, infrequent (Rouillac et al., 1995b; RHD ( (Jones, 1995; Liu et al., 1996; Wagner et al., 1998b) 
RHD(G353R)
exon 7 G→A at 1059 DNU CDe -not reported (Avent et al., 1997a) RHD/RHCE alleles with single or multiple short conversions RHD(S103P)
anti-G, one sample (Faas et al., 1996) RHD ( strong, few samples (Rouillac et al., 1995a; Huang, 1997b) RHD/RHCE hybrid alleles (single larger conversions)
CDe -strong, several samples (Beckers et al., 1996a ) (Jones, 1995; Liu et al., 1996) RHD-Ce ( weak, one sample (Lomas et al., 1994; Rouillac et al., 1995a) RHD-cE ( weak, few samples (Beckers et al., 1996c; Beckers et al., 1996d) *Allele nomenclature in accordance with published recommendations (Beaudet et al., 1996; Beutler et al., 1996) . Most known aberrant RHD alleles are shown excluding D --, molecular weak D types and RhD-negative phenotypes (see Table 3 ). A characterization of more than 15 alleles, all represented by mis-sense mutations, for molecular weak D types is forthcoming (Wagner et al., 1998b) . †Reviewed by Tippett et al. (1996) . Partial D was defined (Salmon et al., 1984) , the D category phenotypes can be subdivided by molecular characterization. ‡Summarized by Jones et al. (1995) and in the cited source reports. §Unexpectedly, RHD intron 4 was reported to be present (Jones, 1995) . A full characterization is pending. ¶In a blood sample kindly provided by Zhu Zi-yan, Shanghai, China .
developed and are faster and easier than conventional phenol-chloroform and salting-out procedures, but should be carefully controlled for batch-to-batch variations. Fully automated validated commercial systems to extract nucleic acids from cells will help to facilitate and standardize this crucial step, which should be checked in quality control programmes. Substantial advances in the quality of commercial thermocyclers during the past decade have shifted the realization of adequate reaction conditions for the PCR from a delicate technical problem to a highly reproducible routine procedure. Hot-start PCR techniques efficiently suppress mispriming. In a modular set-up several PCR-SSPs are performed in separate test tubes and analysed in parallel. In a multiplex set-up two or more PCR-SSPs are run in one test tube. Integrating several different primer pairs into a multiplex PCR in a single tube offers the important advantage of increasing the efficiency of genotyping by reducing the number of procedures and the required amounts of both DNA and reagents. PCR methods for successfully accommodating 11 or even more primer pairs in a single tube have been described (Lin et al., 1996) . In DNA samples that contain only small amounts of contaminants interfering with PCR the yield of amplicons from a few primer pairs may still be sufficient; DNA samples of lesser purity and quality may be more representative of the routine situation and prone to yield less reliable results. Thus, multiplex PCR has to be most thoroughly optimized and standardized to accommodate adequate amplification from DNA samples of variable quality.
Amplicon detection
RHD and RHCE allele-specific amplicons synthesized by PCR are easily detected by electrophoresis in agarose gels followed by ethidium bromide staining. Sensitivity of this step is appropriate for the investigation of many samples and can be further improved by using either acrylamide gels or different dyes for staining, such as SYBR green I or silver. When testing a large number of samples, gel electrophoresis can easily limit the sample throughput. ELISA detection of amplicons is feasible by digoxigenin-or fluorescein-labelled primers used in combination with a biotinylated primer (Legler et al., 1996; Müller et al., 1997a) . Incorporation of biotin into the PCR products allows capture of the amplicons on an avidin-coated microtitre plate (Fischer et al., 1995) ; digoxigenin and fluorescein antibodies then offer convenient means for detection of amplicons in hundreds of samples and for automation APPLICATION OF PCR-SSP TO RH DNA TYPING PCR using sequence-specific priming (PCR-SSP), also known as allele-specific primer amplification (ASPA), allows the specific detection of nucleotides at predetermined sequence positions. PCR-SSP can be devised to suit modular and multiplex PCR set-ups, may be adapted for detection of most nucleotide polymorphisms and for standardized thermocycling conditions, and is rapid. Thus, PCR-SSP is preferred for RH DNA typing by most research groups and in more recent PCR set-ups (Table 4) .
Single primer pairs
As noted previously, PCR set-ups with a single primer pair only are not considered reliable and should not generally be applied for diagnostic purposes. They may be very useful to distinguish and characterize rare alleles. Limited studies with new primer pairs for single sites are conducted to establish specificity and robustness, before a primer pair is added to established modular or multiplex systems.
Modular systems
With PCR set-ups comprising two or more primer pairs the rate of false positive and false negative results can be diminished. However, samples of unknown RHD structure may still be retrieved, whose clinical relevance is not immediately apparent. We developed a modular RHD PCR-SSP system consisting of seven PCR reactions specific for RHD exons 3-7, 9 and 10 plus one PCR reaction detecting exon 2 of RHD or the C allele of RHCE (Table 1 and Fig.  2 ). To maximize the information obtained about the protein sequence, only nucleotide substitutions determining amino acid polymorphisms were chosen for detection. The screening of all RHD exons differing from RHCE allows the identification of any RHD-CE-D hybrid allele that involves at least one full exon, because the lack of any RHD-specific exon would always be detected by one or more negative RHD-specific reaction. This system proved very efficient for the rapid identification and preliminary characterization of new forms of partial D due to RHD-CE-D hybrid proteins Wagner et al., 1998a) . Additional PCR-SSP reactions may be added to detect partial D, like D VII , caused by mis-sense mutations (Fig. 2) .
The RHD typing system is complemented by six PCR reactions detecting the Rh antigens C ( Table 1 and Fig. 2) . Typing for the C allele of RHCE was generally considered difficult and unreliable : the identity of RHD alleles and the C allele of RHCE in exon 2 prevents the specific detection of the C allele in RHD-positive samples by these nucleotide positions. Typing for the C allele at position 48 in exon 1 was also unreliable Gassner et al., 1997b; Faas, 1998) . This was recently explained by our finding that C48 is shared by a c allele occurring in most cDe ) and a few cde haplotypes (own unpublished observation; Tanaka et al., 1997) . In the meantime we added a Callele-specific PCR-SSP (Gassner et al., 1997a) based on a C-allele-specific intron 2 polymorphism to our modular PCR set-up. A C-allele-specific DNA typing performed with this reaction was concordant with the C antigen serology without exception in more than 500 samples investigated (unpublished observations) rendering this system reliable for C-allele-specific DNA typing. Although data from the African populations are lacking, a similar excellent concordance is predicted, if the high false-positive rate in Africans can be explained by the prevalance of the cDe haplotype in that population. The sequence of the c alleles of RHCE is identical either to the sequence of the C alleles of RHCE or to RHD alleles in all exons but exon 2. Hence, typing for a c allele of RHCE is performed utilizing two polymorphic nucleotide positions in exon 2 (Table 1 ). The only difference between the E and e alleles of RHCE is a C (E alleles)/G (e alleles) polymorphism at position 676 located in exon 5. The RHD alleles share the G at position 676. A PCR-SSP detecting this polymorphic nucleotide only may hence coamplify all RHD-positive haplotypes. For this reason, the PCR-SSP reactions for the E/e polymorphism utilizes two sequence-specific primers: one primer detects an RHCE-specific nucleotide at position 787 and suppresses the coamplification of all RHD alleles, and the other discriminates the E/e polymorphism at position 676 by being specific for either the E or the e alleles of RHCE (Table 1) . Finally, a reaction detecting position 122 in exon 2 specific for the C w allele was recently added to our modular typing system (Table  1 and Fig. 2 ).
In summary, a total of 15 PCR-SSP reactions detect 17 of about 41 amino acid polymorphisms crucial for most antigen specificities of the Rh blood group system. This enabled us to type samples with an unprecedented accuracy. Since all PCR-SSP reactions are performed with identical thermocycling conditions, the number of PCR reactions does not affect the assay time. If the detection of alleles, defined by many other mis-sense mutations and coding for Rh antigens, like D II , DNU, DHR, DHMi, C x , RH26 and VS, is considered important, additional modules may be added easily. On the other hand, RHD-specific reactions may be omitted if they were shown redundant for a given accuracy in any distinct population. Most importantly for a rational testing strategy, RHD PCR-SSP modules specific for nonfunctional RHD alleles may be added as soon as their occurrence and molecular cause is identified (Table 3) . Once a modular system for RH DNA typing is established, it may be easily transferred to applications using fluorescence and otherwise labelled primers.
Modular systems with fluorescence-labelled primers
Fluorescence detection in a modular PCR-SSP for RHD/ CE DNA typing has been shown to enhance the assay sensitivity (Tonn et al., 1997) . Promising technologies have been introduced to detect newly formed amplicons whilst the PCR amplification is still in progress (Heid et al., 1996; Morris et al., 1996; Kalinina et al., 1997; Woo et al., 1998) . A relevant DNA stretch is amplified by PCR using sequence-specific priming, for example. A short oligonucleotide ('TaqMan probe') carrying a fluorescence dye as reporter at its 5 0 end and a quencher dye at its 3 0 end can hybridize specifically to the amplicon. The ensuing PCR releases the reporter dye from the probe due to the 5 0 nuclease activity of the polymerase. The released fluorescence dye no longer being quenched is indicative of the amount of amplicons produced. In arrays of 96 samples, the change of fluorescence in closed PCR tubes can be detected simultaneously and offers an extraordinarily efficient and quantitative read out whilst the PCR thermocycling is still under way. This VI type I alleles. The CcDee phenotype in panel D shows specific products in all PCR-SSP reactions geared to detect RHD exons. Specific products were also found in the RHCE PCR-SSP reaction of all four samples in concordance with their RhCE phenotypes. The 434-bp internal control amplicon, which was devised to be larger than any RH-specific amplicon, may be suppressed because of competition, if a specific product is amplified.
technology reduces dramatically the risk of contamination by amplicons generated during the PCR.
Multiplex systems
In multiplex systems, several specific PCR reactions are performed in a single tube. This allows detection of more than one polymorphism in a single DNA sample and in one PCR reaction. The development of advanced multiplex systems is a laborious task. The different PCR reactions must be orchestrated to work with equal efficiencies under the same thermocycling conditions and without loss of specific bands due to competition.
The first multiplex systems proposed for RHD DNA typing involved combinations of the intron 4 length polymorphism with the exon 10 SSP reaction (Spence et al., 1995a; Pope et al., 1995) and included specific PCR products of up to 600 bp length. To improve the stability of the intron 4 system, Avent et al. (1997c) engineered two PCR-SSP reactions whose sequencespecific primers are located in the RHCE intron 4 sequence and span the RHD deletion point. These two reactions were combined with an exon-10-based RHD PCR-SSP resulting in a true SSP multiplex system detecting RHD intron 4 and exon 10. This system was useful for screening a large number of samples for aberrant RHD alleles and led to the identification of the RHD(Q41X) allele. The authors' data indicated that false positive results due to sporadic mutations may be frequent among Cde and cdE haplotypes and may remain a problem even for multiplex systems. recently presented a multiplex system that incorporates reactions for RHD exons 3, 4, 5, 6, 7 and 9, all the informative RHD exons, along with a b-actin control, in a single tube. Specific products range from 157 to 57 bp and were visualized in a polyacrylamide gel (Fig. 3 , gel image courtesy of P. A. Maaskant-van Wijk). This elaborate system allowed the correct identification of all known RHD-CE-D hybrid alleles with the only exception of D IIIb . The inclusion of so many reactions into a single tube is complicated, and internal mismatch bases had to be introduced into several primers to increase specificity. Furthermore, strict quality control is needed, because with a DNA concentration of less than 10 ng, specific bands may be lost while the control band is still amplified. Full concordance for all 292 W. A. Flegel et al. ᭧ 1998 Blackwell Science Ltd, Transfusion Medicine, 8, 281-302 ) were identified, suggesting that these partial D are frequent among non-Caucasians. The authors proposed the application of this single tube system for prenatal testing and for population screening, which would facilitate the immediate identification and classification of most partial D.
Multiplex systems with fluorescence labelled primers
We have developed a strategy for RHD/CE DNA typing in large numbers of samples , which is outlined in Fig. 4 . Fifteen primer pairs specific for RHD or RHCE were used in four multiplex PCR reactions to amplify RHD/CE-allele-specific segments. One primer of each pair is labelled with either 6-carboxy-fluorescein, tetrachloro-6-carboxyfluorescein or hexachloro-6-carboxy-fluorescein. The PCR products of all four tubes with the same DNA sample are pooled after completion of the PCR reactions and the primers are removed by adsorption to columns. The pooled amplicons are finally separated by capillary electrophoresis and fluorescence detection of the labels using an automated nucleotide sequencer (ABI Prism Genetic Analyser 310; Applied Biosystems, Foster City, CA, USA). Electrophoretic separation of up to 15 different products from the multiplex PCR in a 47-cm-long capillary (0·05 mm internal diameter) filled with the POP-6 polymer is completed within 25 min after injection of the sample. A highly reproducible measurement of the size of the amplicons is ensured by comparison of the retention times of the amplicons to those of internal standards of defined size. Combining these size measurements with analysis of the fluorescence of the different dyes reliably identifies the products generated by multiplex PCR. Up to 96 samples, which may contain the mixed products of the four multiplex PCR, are automatically injected and analysed sequentially. Validation experiments demonstrate the high reliability (concordant results with serotyping for samples from 100 donors) and good sensitivity (adequate for the analysis of samples from amniotic fluid) of this approach. This method of multiplex PCR with fluorescent primers together with automated identification of the pooled amplification products allowed semiautomated RHD/CE genotyping based on a multitude of 'diagnostic' DNA polymorphisms.
OTHER TECHNIQUES SUITABLE FOR DETECTING KNOWN SEQUENCE POLYMORPHISMS
Several alternatives to PCR-SSP are available to detect defined sequence polymorphisms. Some lack the versatility of PCR-SSP or have not yet been applied to RH DNA typing.
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᭧ 1998 Blackwell Science Ltd, Transfusion Medicine, 8, 281-302 Fig. 4 . Outline of a blood group genotyping strategy suitable for testing large numbers of blood samples. As an example, the application to multiplex RHD/CE DNA typing is shown. PCR amplification of many DNA fragments is performed in a modular fashion using fluorescence-labelled sequence-specific primers. After primer removal the amplicons can be specifically detected according to their fragment length and colour. The reading is achieved in an automated procedure by capillary electrophoresis followed by fluorescence detection. The procedure lends itself to automatic data retrieval, interpretation and documentation. Other large-scale genotyping procedures currently being developed are discussed in the text.
PCR amplicon hybridization with sequence-specific oligonucleotides (PCR-SSO)
PCR amplicon capturing to a solid phase, like filters and microtitre wells, followed by hybridization with sequence-specific oligonucleotides, or the 'reverse dot technique', is widely used for HLA genotyping. Although no applications for RH DNA typing have been established, the potential for automation, such as with enzyme-linked detection systems, is great. The knowledge of allele polymorphisms established by PCR-SSP can be easily applied to PCR-SSO.
Ligase chain reaction
The ligase chain reaction involves cyclic, sequencedependent ligation of two oligonucleotides and is often used as a second step following PCR amplification. The combination of a biotin-labelled oligonucleotide with a digoxygenin-labelled oligonucleotide allows detection of the ligation product by ELISA, making this method amenable to automation. To date, a single application for RH DNA typing has been described (Maas et al., 1997) .
PCR amplicon length polymorphism
In the introns of the RH genes, there are several insertions, deletions and repeat number polymorphisms. Amplification of these regions by flanking primers results in amplicons of gene or allele-specific lengths that can be separated by gel electrophoresis. RHDspecific sequences and RHCE-specific controls are amplified in the same tube by the same primer pair, obviating the need for additional controls. The first and a major application is RHD typing by an intron 4 deletion (Arce et al., 1993) . The linkage of intron polymorphisms to RH phenotypes is excellent and some systems, like the detection of the C allele by virtue of an intron 2 insertion , are more informative than exonbased assays. Technical limitations may be encountered because PCR conditions depend on the length of the investigated deletion. They tend to involve comparably long extension periods, which often prevents the technique from being suitable for modular systems. Then, PCR-SSP devised for the same polymorphism (Avent et al., 1997c; Gassner et al., 1997a) may be more useful.
PCR combined with restiction fragment length polymorphism (PCR-RFLP)
PCR amplicon digestion by restriction enzymes and analysis of the restriction fragment length polymorphism may detect single nucleotide substitutions located in restriction sites. A major application is c/D typing in intron 2 . Enzyme digestion may take less than 2 min if it is performed by microwave heating . Sufficient digestion should be controlled by an additional restriction site present in all amplicons. PCR-RFLP is easy to establish if a restriction site happens to incorporate the polymorphic site (Beckers et al., 1996b) , but this is not the rule. Compared to PCR-SSP, there is more hands-on time and much less potential for modular set-ups.
TECHNIQUES SUITABLE TO DETECT UNEXPECTED SEQUENCE POLYMORPHISMS PCR-SSP and the similar methods presented in the preceding sections are geared to detect distinct known polymorphisms and they will rarely detect other nucleotide sequence aberrations by chance. Several techniques do not aim for specific nucleotide polymorphisms but allow screening for aberrations occurring in longer stretches of a nucleotide sequence. Hence, for example, sporadic non-sense mutations may not escape detection, which furthers the test specificity. The enhanced information retrieval must be weighed against the increased complexity of the assays. Furthermore, routine application may be hampered by the detection of frequent (Stoerker et al., 1996) , yet clinically irrelevant, silent or intronic mutations, which may incur clinically futile work-up. In the field of RH typing, denaturing gradient gel electrophoresis, heteroduplex analysis, single-strand conformation polymorphism and conventional sequencing have been utilized.
Denaturing gradient gel electrophoresis (DGGE)
In DGGE, double-stranded PCR amplicons are electrophoresed through a gradient of a denaturing agent of increasing concentration. At a characteristic concentration, part of the double-stranded DNA sequence begins melting, which results in an abrupt decrease of mobility and a characteristic sequence-dependent pattern (Fischer & Lerman, 1983) . Electrophoresis usually takes 24 h and gel conditions must be specifically adapted for each amplicon, restricting DGGE largely to research questions. DGGE has been applied to RH exons 2 and 5 (Steers et al., 1996) .
Heteroduplex analysis
Heteroduplexes containing single base mismatches can be separated from homoduplexes and other heteroduplexes by nondenaturing gel electrophoresis. Engineered DNA fragments with small deletions may ensure heteroduplex generation for almost any allele. Heteroduplex systems have been developed for exons 2 and 5 (Stoerker et al., 1996) and applied for routine use (Rose et al., 1997) .
Single-strand conformation polymorphism (SSCP)
The electrophoretic behaviour of single-stranded DNA in nondenaturing gels depends on sequence-specific secondary structures. This biological feature is utilized in SSCP. After denaturing by heat, electrophoresis can be performed in about 15 min. SSCP is hence much faster and simpler than DGGE or heteroduplex analysis. It is less sensitive and may miss about 20% of mutations. Recently, SSCP was utilized for screening for the G286A mutation determining the Rh:-26 phenotype (Faas et al., 1997c) .
Conventional sequencing
The gold standard for nucleotide sequence determination is the full length sequencing of the desired stretch of the nucleic acid. The classical approach for the definition of aberrant RH alleles involves RNA isolation, reverse transcription, subcloning and plasmid sequencing. The procedure is very laborious and prone to mistakes because of splice variants, which are particularly abundant among RH transcripts. Identification of mis-sense mutations may be hampered by misincorparated nucleotides introduced by PCR and selected by subcloning of the plasmids.
Genomic sequencing has been used for screening for the D VII mutation . It is less laborious and obviates the need for subcloning, but the detection rate for heterozygotes may be less than 100%. Recently, we developed an RHD-specific genomic sequencing system for all exons obviating the need for subcloning (Wagner et al., 1998b) . If hybrid alleles involving large gene conversions are excluded by PCR-SSP, this approach allows sequence determination of the full coding sequence with an expected detection rate of 100% within 3 working days. The utility of this system has been demonstrated by the identification of more than 15 alleles constituting the molecular cause of the weak D phenotype .
FUTURE TECHNOLOGIES: BIOCHIPS
Biochips and PCR chips (Chee et al., 1996; Wodicka et al., 1997) could be used to determine the nucleotides at each of the Ϸ 37 exon positions differing between the RHCE and the RHD genes. Presently it is doubtful if this resolution is really needed for clinically relevant RH DNA typing. Only population-wide sequence characterization of many RHD and RHCE alleles will adequately address this question. However, with much improved cost-efficiency the resolution of all cDNA nucleotide positions revealing all possible non-sense mutations might become feasible and would enhance the reliability for future RH genotyping to unprecedented levels clearly exceeding the precision of any serology-based method.
TOWARDS A RATIONAL TESTING STRATEGY
There is currently no optimal RH DNA typing strategy suiting all applications. DNA typing is performed for different populations and for different purposes. It is apparent from the previous sections that the techniques vary widely from few or multiple PCR reactions performed in separate tubes to multiplex reactions in single tubes. The use of two or more 'diagnostic sites' is recommended to limit the rate of false results. Furthermore, the equipment for and experience with genotyping systems, which may be available in a laboratory, will often guide the selection for a particular RH DNA typing system. For the broader application in clinical routine laboratories a PCR-based approach in conjunction with the specific detection of certain nucleotide positions by sequence-specific oligonucleotides is generally favoured.
Importance of the population tested
The polymorphisms (alleles) of a gene, their population frequencies and distribution in the examined population have critical importance for the practical application of DNA typing. Most RH DNA typing data derive from Caucasians. In African and Japanese people, there is a large fraction of RhD-negative alleles that harbour RHDspecific sequences and are not correctly recognized with almost any published strategy. The more frequent partial D differ between non-Caucasian (D IVa ) and Caucasian (D VII ) populations. Reliable RH DNA typing in nonCaucasian populations will have to await the identification of the more prevalent alleles in RhD-negative samples present in those populations. DNA typing in random samples without reference to the allele pool involved, i.e. the genetic derivation of the probands, is prone to mistakes. At the moment, the rate of false Rh phenotype predictions in populations other than Caucasians cannot be estimated reliably. Admixtures to the allele pool introduced by non-Caucasians may hamper RH DNA typing even in Western populations.
The Japanese RhD-negative samples may represent a special problem because they were reported to possess a normal RHD promoter, plentiful RHD mRNA, and an RHD coding sequence with a single mis-sense mutation that appeared not to be diagnostic. If high-precision DNA typing is attempted, the prevalence of rare variants may become more important. Genotypes underlying partial D, for example D category VI, vary even within closely related Caucasian populations (Wagner et al., 1998a) . The relevant questions may be answered by population-based approaches, which may, if properly conducted, yield interesting data for scientific problems.
Which polymorphism should be tested?
The expense of a genotyping system must be weighed against its residual failure rate in phenotype prediction to determine its cost-efficiency. In almost all current genotyping strategies rather short nucleic acid sequences are utilized. Full coverage of the cDNA is not practical with the available technology, and full coverage of a gene cannot even be attempted. Therefore, the phenotype prediction depends critically on the functional integrity of the detected allele (Flegel, 1997) . To limit false positive RHD DNA typing, there is unfortunately no expedient alternative method to specifically detect the multiple RHD sequence aberrations occurring in RhDnegative phenotypes (Table 3) . Because these alleles occur with moderate frequencies even in Caucasians, genotyping strategies should address this problem.
DNA typing experience with rare phenotypes (Avent et al., 1997c) and the phenotype frequency data (Wagner et al., 1995) indicated that the correct Rh phenotype is predicted in more than 99·5% of unselected samples from Caucasians even by testing of a single polymorphism only. The detection of a second polymorphism raises accuracy to about 99·9% (Table 4) , which is currently the recommended approach (Bennett & Cartron, 1994; Simsek et al., 1994; Lighten et al., 1995) . If two polymorphisms are to be tested, we favour two 'diagnostic sites' located in exon 4/intron 4 and in exon 7 (Table 1) . By this approach, the clinically most relevant partial D, D VI and D
IV
, are recognized and the RhD-negative alleles due to RHD-CE-D hybrids involving substitutions in exons 4-7 (Table 3) are correctly predicted as RhD-negative. If three polymorphisms are to be tested, we recommend sites located in exons 4, 5 and 7 because this approach would test all three exofacial loops differing between RHD and the C allele of RHCE. To increase the specificity further, all RHD-specific exons can be tested (Table 1 and Fig. 2) . However, the estimated frequency of partial D due to RHD-CE-D hybrid alleles other than D VI and D IV is less than 1 : 10 000 among unselected samples from Caucasians Roubinet et al., 1996) .
Importance of the application
For paternity testing, usually DNA of the mother, child and putative father is available. As long as results are obtained with the same method for all involved persons, mismatches between phenotype and DNA type will not affect paternity prediction. The frequency discrepancy between DNA-based and phenotypic haplotypes is usually too small to affect probability calculations significantly. Hence, a robust single polymorphism assay can be considered sufficient (van den Veyver et al., 1996) . Methods, like DGGE, that allow the detection of sporadic aberrant RH alleles may enhance somewhat the predictive value of RH DNA typing in paternity testing if one of the persons possesses a rare aberrant allele. It remains doubtful whether this small advantage merits the additional effort of more complicated test systems.
For prenatal prediction of the Rh phenotype in Caucasians, typing errors due to technical problems including contamination with maternal blood are likely to influence the error rate more than the residual 0·1% of rare alleles that may be mistyped. Hence, for prenatal testing, a robust modular or multiplex system involving two or more polymorphisms may be chosen. Because of the lower rate of fetal loss incurred by the less invasive sampling procedures (van den Veyver & Moise, 1996) , the RHD DNA typing is today clearly the method of first choice for predicting the fetal RhD phenotype.
On the other hand, a 99·9% accuracy is not sufficient if a replacement for routine serological methods is required. Contrary to a common perception, the major obstacle for Rh phenotype prediction is those RhDnegative phenotypes that carry RHD-specific DNA stretches (Table 3) rather than partial D. In Caucasians, such samples occurred with a frequency of about 5% among Ccddee and ccddEe samples (Avent et al., 1997c) , resulting in an estimated population frequency of about 1 : 1000-2000. This rate exceeds by far that of clinically relevant partial D, like D VI (Wagner et al., 1995) . Hence, further advances in RH DNA typing of unselected individuals is unlikely to be achieved by adding more RHD exon-specific reactions only. Improvements will rather necessitate the identification and specific detection of nonfunctional RHD alleles. In this respect, modular approaches have the advantage that additional reactions may be easily incorporated.
A quite different situation concerns the screening of phenotypically abnormal samples, for example partial D and weak D. In partial D, an aberrant RHD sequence may almost always be detected, whereas a serological discrimination can be cumbersome or misleading. Exon scanning RHD PCR Maaskantvan Wijk et al., 1997b) identifies those interesting samples of hybrid RHD/CE structure rapidly that merit further characterization by cDNA sequencing. For RHD alleles with point mutations, genomic sequencing (Wagner et al., 1998b) is today the most straightforward and rapid approach. The improved resolution achieved by PCR detection of multiple RHD-specific products is useful for population surveys to elaborate the genetic basis of the various RhD and RhCE phenotypes.
Laboratory-specific considerations
Within the mentioned framework of RH DNA typing strategies, the selection of a specific DNA typing system may be guided by practical considerations specific for a particular laboratory. The more expedient of two otherwise comparable systems will generally be preferred. Often, it is advantageous to select an RH DNA typing system with thermocycling conditions already applied in the laboratory for other purposes, such as HLA genotyping. Investigators less experienced with DNA typing may prefer robust test systems, which are only marginally affected by variable DNA quality. ELISA-or fluorescence-based systems necessitate special equipment, but are likely to vastly outperform other systems if largescale DNA typing is attempted.
CONCLUSION
Blood group phenotype prediction by molecular methods is feasible and for some applications are already superior to standard serological phenotyping. Examples for RH DNA typing are prenatal diagnostics and characterization of aberrant Rhesus proteins including partial D.
Personally, we will not be surprised if genotyping eventually replaces 'immunotyping' as the standard procedure in the blood group laboratory. This prediction is being questioned by some in the profession pointing to the many major problems that are -at the momentundeniably associated with blood group genotyping. Many technical increments are required to achieve vast improvements in the reliability and cost-efficiency of genotyping, which are relatively low compared to standard serological methods. Once the many problems are addressed, they can be solved in a piecemeal approach, which will step by step reduce genotyping to routine practice for most applications currently tackled by serology. It is hoped that establishing the necessary population data will keep pace with the rapidly improving technologies in genotyping. Our profession could contribute considerably to the improvement of genotyping strategies that are vigorously developed in various medical fields.
ABO and RhD typing are among the most reliable diagnostic procedures. Being rather inexpensive is one reason that blood group serology is very cost-efficient, if applied prudently. In this situation, the demands required for blood group genotyping are exceptional compared to genotyping for other purposes. By striving to meet these demands for blood group genotyping, transfusion medicine may well contribute to the understanding of and the solutions for the biological problems associated with genotyping strategies in general.
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